AskTheDate.com
Back to calendar

Xeris Biopharma Holdings, Inc. (XERS) Earnings

XERS reports earnings on Thursday, August 6, 2026

earnings report
August 6, 2026
Q2 2026
Est. EPS: $0.04
Actual EPS: $-0.18
EPS surprise: -1582.34%
Company overview
Market Cap$1.5B
PriceUSD 8.49
EPS (TTM)-0.10
52-week high10.08
52-week low5.25
SectorHealth Technology
IndustryBiotechnology
Employees435